The Time Course of Compensatory Puffing With an Electronic Cigarette: Secondary Analysis of Real-World Puffing Data With High and Low Nicotine Concentration Under Fixed and Adjustable Power Settings.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
08 06 2021
Historique:
received: 15 05 2020
accepted: 18 01 2021
pubmed: 24 1 2021
medline: 27 10 2021
entrez: 23 1 2021
Statut: ppublish

Résumé

In a secondary analysis of our published data demonstrating compensatory vaping behavior (increased puff number, puff duration, and device power) with e-cigarettes refilled with low versus high nicotine concentration e-liquid, here we examine 5-day time course over which compensatory behavior occurs under fixed and adjustable power settings. Nineteen experienced vapers (37.90 ± 10.66 years, eight females) vaped ad libitum for 5 consecutive days under four counterbalanced conditions (ie, 20 days in total): (1) low nicotine (6 mg/mL)/fixed power (4.0 V/10 W); (2) low nicotine/adjustable power; (3) high nicotine (18 mg/mL)/fixed power; (4) high nicotine/adjustable power (at 1.6 Ohm). Puff number, puff duration, and power settings were recorded by the device. For each day, total daily puffing time was calculated by multiplying daily puff number by mean daily puff duration. A significant day × setting interaction revealed that whilst puffing compensation (daily puffing time) continued to increase over 5 days under fixed power, it remained stable when power settings were adjustable. Separate analysis for puff number and puff duration suggested that the puffing compensatory behavior was largely maintained via longer puff duration. Under fixed power conditions (4.0 V/10 W), vapers appear to compensate for poor nicotine delivery by taking longer puffs and this compensatory puffing appears to be maintained over time. Studies in smokers suggest that when switching to lower nicotine levels, compensation for poorer nicotine delivery is transient. Our novel findings suggest that vapers show a different pattern of compensation which is influenced by both nicotine strength and device power settings. When power is fixed (4.0 V; 10 W), compensation (via more intensive puffing) appears prolonged, persisting up to 5 days. Under adjustable settings when power is increased, puffing patterns remain stable over time. Implications of such compensatory behaviors for product safety and user satisfaction need further exploration.

Identifiants

pubmed: 33483754
pii: 6114004
doi: 10.1093/ntr/ntab013
pmc: PMC8186419
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1153-1159

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA037446
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA228110
Pays : United States
Organisme : Cancer Research UK
ID : C50878/A21130
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1417/A22962
Pays : United Kingdom

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.

Références

Psychopharmacology (Berl). 2012 Sep;223(1):47-54
pubmed: 22427021
Sci Rep. 2020 Apr 16;10(1):6546
pubmed: 32300142
Psychopharmacology (Berl). 2016 Aug;233(15-16):2933-41
pubmed: 27235016
N Engl J Med. 2015 Oct;373(14):1340-9
pubmed: 26422724
Przegl Lek. 2016;73(10):699-703
pubmed: 29688686
Drug Alcohol Depend. 2007 Jan 12;86(2-3):294-300
pubmed: 16930853
Nicotine Tob Res. 2018 Jul 9;20(8):998-1003
pubmed: 29065196
Psychol Bull. 1983 Mar;93(2):302-27
pubmed: 6844475
J Psychosom Res. 1980;24(5):253-64
pubmed: 7205714
Addict Biol. 1998 Oct;3(4):383-404
pubmed: 26735114
BMC Public Health. 2016 Sep 20;16:999
pubmed: 27650300
Nicotine Tob Res. 2018 Jul 9;20(8):993-997
pubmed: 29059377
Addiction. 2018 Oct;113(10):1874-1882
pubmed: 29882257

Auteurs

Sharon Cox (S)

Department of Behavioural Science and Health, University College London, London, UK.

Maciej L Goniewicz (ML)

Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Leon Kosmider (L)

Department of General and Inorganic Chemistry, Medical University of Silesia, Katowice FOPS in Sosnowiec, Sosnowiec, Poland.

Hayden McRobbie (H)

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.

Catherine Kimber (C)

Centre for Addictive Behaviours Research, London South Bank University, London, UK.

Lynne Dawkins (L)

Centre for Addictive Behaviours Research, London South Bank University, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH